Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 71

1.

Getting local: focusing on communities to achieve greater impact in the next phase of the HIV response.

Fakoya AO, Dybul MR, Sands P.

J Int AIDS Soc. 2019 Jul;22(7):e25366. doi: 10.1002/jia2.25366. No abstract available.

2.

Can Changes in Service Delivery Models Improve Program Quality and Efficiency? A Closer Look at HIV Programs in Kenya and Uganda.

Kandasami S, Shobiye H, Fakoya A, Asiimwe S, Inimah M, Etukoit M, Morrison L, Johnson M, Dybul M.

J Acquir Immune Defic Syndr. 2019 Aug 15;81(5):533-539. doi: 10.1097/QAI.0000000000002064.

3.

Building a tuberculosis-free world: The Lancet Commission on tuberculosis.

Reid MJA, Arinaminpathy N, Bloom A, Bloom BR, Boehme C, Chaisson R, Chin DP, Churchyard G, Cox H, Ditiu L, Dybul M, Farrar J, Fauci AS, Fekadu E, Fujiwara PI, Hallett TB, Hanson CL, Harrington M, Herbert N, Hopewell PC, Ikeda C, Jamison DT, Khan AJ, Koek I, Krishnan N, Motsoaledi A, Pai M, Raviglione MC, Sharman A, Small PM, Swaminathan S, Temesgen Z, Vassall A, Venkatesan N, van Weezenbeek K, Yamey G, Agins BD, Alexandru S, Andrews JR, Beyeler N, Bivol S, Brigden G, Cattamanchi A, Cazabon D, Crudu V, Daftary A, Dewan P, Doepel LK, Eisinger RW, Fan V, Fewer S, Furin J, Goldhaber-Fiebert JD, Gomez GB, Graham SM, Gupta D, Kamene M, Khaparde S, Mailu EW, Masini EO, McHugh L, Mitchell E, Moon S, Osberg M, Pande T, Prince L, Rade K, Rao R, Remme M, Seddon JA, Selwyn C, Shete P, Sachdeva KS, Stallworthy G, Vesga JF, Vilc V, Goosby EP.

Lancet. 2019 Mar 30;393(10178):1331-1384. doi: 10.1016/S0140-6736(19)30024-8. Epub 2019 Mar 20. Review. No abstract available.

PMID:
30904263
4.

Advancing global health and strengthening the HIV response in the era of the Sustainable Development Goals: the International AIDS Society-Lancet Commission.

Bekker LG, Alleyne G, Baral S, Cepeda J, Daskalakis D, Dowdy D, Dybul M, Eholie S, Esom K, Garnett G, Grimsrud A, Hakim J, Havlir D, Isbell MT, Johnson L, Kamarulzaman A, Kasaie P, Kazatchkine M, Kilonzo N, Klag M, Klein M, Lewin SR, Luo C, Makofane K, Martin NK, Mayer K, Millett G, Ntusi N, Pace L, Pike C, Piot P, Pozniak A, Quinn TC, Rockstroh J, Ratevosian J, Ryan O, Sippel S, Spire B, Soucat A, Starrs A, Strathdee SA, Thomson N, Vella S, Schechter M, Vickerman P, Weir B, Beyrer C.

Lancet. 2018 Jul 28;392(10144):312-358. doi: 10.1016/S0140-6736(18)31070-5. Epub 2018 Jul 20. Review. No abstract available.

5.

Global governance of antimicrobial resistance.

Rochford C, Sridhar D, Woods N, Saleh Z, Hartenstein L, Ahlawat H, Whiting E, Dybul M, Cars O, Goosby E, Cassels A, Velasquez G, Hoffman S, Baris E, Wadsworth J, Gyansa-Lutterodt M, Davies S.

Lancet. 2018 May 19;391(10134):1976-1978. doi: 10.1016/S0140-6736(18)31117-6. Epub 2018 May 17. No abstract available. Erratum in: Lancet. 2018 May 26;391(10135):2106.

PMID:
29864011
6.

Phylodynamic analysis to inform prevention efforts in mixed HIV epidemics.

Volz EM, Ndembi N, Nowak R, Kijak GH, Idoko J, Dakum P, Royal W, Baral S, Dybul M, Blattner WA, Charurat M.

Virus Evol. 2017 Jul 28;3(2):vex014. doi: 10.1093/ve/vex014. eCollection 2017 Jul.

7.

Ending cervical cancer: A call to action.

Aranda S, Berkley S, Cowal S, Dybul M, Evans T, Iversen K, Moeti M, Osotimehin B, Peterson S, Piot P, Purandare CN, Sidibé M, Trimble T, Tsu VD.

Int J Gynaecol Obstet. 2017 Jul;138 Suppl 1:4-6. doi: 10.1002/ijgo.12182.

8.

Health financing seen from the global level: beyond the use of gross national income.

Dybul M.

Health Econ Policy Law. 2017 Apr;12(2):117-120. doi: 10.1017/S1744133116000396. No abstract available.

PMID:
28332457
9.

Optimum resource allocation to reduce HIV incidence across sub-Saharan Africa: a mathematical modelling study.

McGillen JB, Anderson SJ, Dybul MR, Hallett TB.

Lancet HIV. 2016 Sep;3(9):e441-e448. doi: 10.1016/S2352-3018(16)30051-0. Epub 2016 Aug 3.

10.

Building from the HIV Response toward Universal Health Coverage.

Jay J, Buse K, Hart M, Wilson D, Marten R, Kellerman S, Odetoyinbo M, Quick JD, Evans T, Piot P, Dybul M, Binagwaho A.

PLoS Med. 2016 Aug 16;13(8):e1002083. doi: 10.1371/journal.pmed.1002083. eCollection 2016 Aug.

11.

The Vancouver Consensus: antiretroviral medicines, medical evidence, and political will.

Beyrer C, Birx DL, Bekker LG, Barré-Sinoussi F, Cahn P, Dybul MR, Eholié SP, Kavanagh MM, Katabira ET, Lundgren JD, Mworeko L, Pala M, Puttanakit T, Ryan O, Sidibé M, Montaner JS; Vancouver Consensus Signatories.

Lancet. 2015 Aug 8;386(9993):505-7. doi: 10.1016/S0140-6736(15)61458-1. No abstract available.

PMID:
26293427
12.

Defeating AIDS--advancing global health.

Piot P, Abdool Karim SS, Hecht R, Legido-Quigley H, Buse K, Stover J, Resch S, Ryckman T, Møgedal S, Dybul M, Goosby E, Watts C, Kilonzo N, McManus J, Sidibé M; UNAIDS–Lancet Commission.

Lancet. 2015 Jul 11;386(9989):171-218. doi: 10.1016/S0140-6736(15)60658-4. Epub 2015 Jun 24. Review. No abstract available. Erratum in: Lancet. 2015 Jul 11;386(9989):136.

PMID:
26117719
13.

MDG 6 and beyond: from halting and reversing AIDS to ending the epidemic.

Sidibé M, Dybul M, Birx D.

Lancet. 2014 Sep 13;384(9947):935-6. doi: 10.1016/S0140-6736(14)61222-8. Epub 2014 Jul 26. No abstract available.

PMID:
25073423
14.

Maximising the effect of combination HIV prevention through prioritisation of the people and places in greatest need: a modelling study.

Anderson SJ, Cherutich P, Kilonzo N, Cremin I, Fecht D, Kimanga D, Harper M, Masha RL, Ngongo PB, Maina W, Dybul M, Hallett TB.

Lancet. 2014 Jul 19;384(9939):249-56. doi: 10.1016/S0140-6736(14)61053-9.

PMID:
25042235
15.

Integration and innovation to advance newborn survival.

Berkley S, Dybul M, Godal T, Lake A.

Lancet. 2014 Jul 12;384(9938):e22-3. doi: 10.1016/S0140-6736(14)60691-7. Epub 2014 May 19. No abstract available.

PMID:
24853595
16.

Transformation of HIV from pandemic to low-endemic levels: a public health approach to combination prevention.

Jones A, Cremin I, Abdullah F, Idoko J, Cherutich P, Kilonzo N, Rees H, Hallett T, O'Reilly K, Koechlin F, Schwartlander B, de Zalduondo B, Kim S, Jay J, Huh J, Piot P, Dybul M.

Lancet. 2014 Jul 19;384(9939):272-9. doi: 10.1016/S0140-6736(13)62230-8. Epub 2014 Apr 14.

PMID:
24740087
17.

A grand convergence and a historic opportunity.

Dybul M.

Lancet. 2013 Dec 7;382(9908):e38-9. doi: 10.1016/S0140-6736(13)62344-2. Epub 2013 Dec 3. No abstract available.

PMID:
24309479
18.

[HIV/AIDS, tuberculosis and malaria can now be effectively combated].

Nordström A, Dybul M.

Lakartidningen. 2013 Apr 3-16;110(27-28):1275. Swedish. No abstract available.

PMID:
23951879
19.

A healthy perspective: the post-2015 development agenda.

Berkley S, Chan M, Dybul M, Hansen K, Lake A, Osotimehin B, Sidibé M.

Lancet. 2013 Mar 30;381(9872):1076-7. No abstract available.

20.

Are Thai MSM willing to take PrEP for HIV prevention? An analysis of attitudes, preferences and acceptance.

Wheelock A, Eisingerich AB, Ananworanich J, Gomez GB, Hallett TB, Dybul MR, Piot P.

PLoS One. 2013;8(1):e54288. doi: 10.1371/journal.pone.0054288. Epub 2013 Jan 14.

21.

The new role of antiretrovirals in combination HIV prevention: a mathematical modelling analysis.

Cremin I, Alsallaq R, Dybul M, Piot P, Garnett G, Hallett TB.

AIDS. 2013 Jan 28;27(3):447-58. doi: 10.1097/QAD.0b013e32835ca2dd.

PMID:
23296196
22.

AIDS is not over.

Sidibé M, Piot P, Dybul M.

Lancet. 2012 Dec 15;380(9859):2058-60. doi: 10.1016/S0140-6736(12)62088-1. No abstract available.

PMID:
23245599
23.

The promise of pre-exposure prophylaxis with antiretroviral drugs to prevent HIV transmission: a review.

Hankins CA, Dybul MR.

Curr Opin HIV AIDS. 2013 Jan;8(1):50-8. doi: 10.1097/COH.0b013e32835b809d. Review.

PMID:
23201856
24.

Male sex and the risk of mortality among individuals enrolled in antiretroviral therapy programs in Africa: a systematic review and meta-analysis.

Druyts E, Dybul M, Kanters S, Nachega J, Birungi J, Ford N, Thorlund K, Negin J, Lester R, Yaya S, Mills EJ.

AIDS. 2013 Jan 28;27(3):417-25. doi: 10.1097/QAD.0b013e328359b89b. Review.

PMID:
22948271
25.

The United States President's Emergency Plan for AIDS Relief: a story of partnerships and smart investments to turn the tide of the global AIDS pandemic.

Goosby E, Dybul M, Fauci AS, Fu J, Walsh T, Needle R, Bouey P.

J Acquir Immune Defic Syndr. 2012 Aug 15;60 Suppl 3:S51-6. doi: 10.1097/QAI.0b013e31825ca721. Review. Erratum in: J Acquir Immune Defic Syndr. 2012 Oct 1;61(2):e24. Fauci, Anthony A [corrected to Fauci, Anthony S].

PMID:
22797740
26.

Views of policymakers, healthcare workers and NGOs on HIV pre-exposure prophylaxis (PrEP): a multinational qualitative study.

Wheelock A, Eisingerich AB, Gomez GB, Gray E, Dybul MR, Piot P.

BMJ Open. 2012 Jul 2;2(4). pii: e001234. doi: 10.1136/bmjopen-2012-001234. Print 2012.

27.

Engaging men in prevention and care for HIV/AIDS in Africa.

Mills EJ, Beyrer C, Birungi J, Dybul MR.

PLoS Med. 2012 Feb;9(2):e1001167. doi: 10.1371/journal.pmed.1001167. Epub 2012 Feb 7. Review. No abstract available.

28.

Attitudes and acceptance of oral and parenteral HIV preexposure prophylaxis among potential user groups: a multinational study.

Eisingerich AB, Wheelock A, Gomez GB, Garnett GP, Dybul MR, Piot PK.

PLoS One. 2012;7(1):e28238. doi: 10.1371/journal.pone.0028238. Epub 2012 Jan 11.

29.

Life expectancy of persons receiving combination antiretroviral therapy in low-income countries: a cohort analysis from Uganda.

Mills EJ, Bakanda C, Birungi J, Chan K, Ford N, Cooper CL, Nachega JB, Dybul M, Hogg RS.

Ann Intern Med. 2011 Aug 16;155(4):209-16. doi: 10.7326/0003-4819-155-4-201108160-00358. Epub 2011 Jul 18.

PMID:
21768555
30.

Association of aging and survival in a large HIV-infected cohort on antiretroviral therapy.

Bakanda C, Birungi J, Mwesigwa R, Ford N, Cooper CL, Au-Yeung C, Chan K, Nachega JB, Wood E, Hogg RS, Dybul M, Mills EJ.

AIDS. 2011 Mar 13;25(5):701-5. doi: 10.1097/QAD.0b013e3283437ed7.

PMID:
21160412
31.

Use of generic antiretroviral agents and cost savings in PEPFAR treatment programs.

Holmes CB, Coggin W, Jamieson D, Mihm H, Granich R, Savio P, Hope M, Ryan C, Moloney-Kitts M, Goosby EP, Dybul M.

JAMA. 2010 Jul 21;304(3):313-20. doi: 10.1001/jama.2010.993.

PMID:
20639565
32.

Planning for pre-exposure prophylaxis to prevent HIV transmission: challenges and opportunities.

Kim SC, Becker S, Dieffenbach C, Hanewall BS, Hankins C, Lo YR, Mellors JW, O'Reilly K, Paxton L, Roffenbender JS, Warren M, Piot P, Dybul MR.

J Int AIDS Soc. 2010 Jul 12;13:24. doi: 10.1186/1758-2652-13-24.

33.

A randomized, controlled, trial of short cycle intermittent compared to continuous antiretroviral therapy for the treatment of HIV infection in Uganda.

Reynolds SJ, Kityo C, Hallahan CW, Kabuye G, Atwiine D, Mbamanya F, Ssali F, Dewar R, Daucher M, Davey RT Jr, Mugyenyi P, Fauci AS, Quinn TC, Dybul MR.

PLoS One. 2010 Apr 22;5(4):e10307. doi: 10.1371/journal.pone.0010307.

34.

Lessons learned from PEPFAR.

Dybul M.

J Acquir Immune Defic Syndr. 2009 Nov;52 Suppl 1:S12-3. doi: 10.1097/QAI.0b013e3181bbc98d. Review.

PMID:
19858928
35.

Venice Statement on global health initiatives and health systems.

Atun R, Dybul M, Evans T, Kim JY, Moatti JP, Nishtar S, Russell A.

Lancet. 2009 Sep 5;374(9692):783-4. doi: 10.1016/S0140-6736(09)61588-9. No abstract available.

PMID:
19733777
36.

An assessment of interactions between global health initiatives and country health systems.

World Health Organization Maximizing Positive Synergies Collaborative Group, Samb B, Evans T, Dybul M, Atun R, Moatti JP, Nishtar S, Wright A, Celletti F, Hsu J, Kim JY, Brugha R, Russell A, Etienne C.

Lancet. 2009 Jun 20;373(9681):2137-69. doi: 10.1016/S0140-6736(09)60919-3. Erratum in: Lancet. 2015 Apr 18;385:1510. Cailhol, Johann [added].

PMID:
19541040
37.

Evaluation of the pathogenesis of decreasing CD4(+) T cell counts in human immunodeficiency virus type 1-infected patients receiving successfully suppressive antiretroviral therapy.

Nies-Kraske E, Schacker TW, Condoluci D, Orenstein J, Brenchley J, Fox C, Daucher M, Dewar R, Urban E, Hill B, Guenaga J, Hoover S, Maldarelli F, Hallahan CW, Horn J, Kottilil S, Chun TW, Folino M, Palmer S, Wiegand A, O'Shea MA, Metcalf JA, Douek DC, Coffin J, Haase A, Fauci AS, Dybul M.

J Infect Dis. 2009 Jun 1;199(11):1648-56. doi: 10.1086/598980.

38.

Evolution of drug resistance after virological failure of a first-line highly active antiretroviral therapy regimen in Uganda.

Reynolds SJ, Kityo C, Mbamanya F, Dewar R, Ssali F, Quinn TC, Mugyenyi P, Dybul M.

Antivir Ther. 2009;14(2):293-7.

39.

AIDS: lessons learnt and myths dispelled.

Piot P, Kazatchkine M, Dybul M, Lob-Levyt J.

Lancet. 2009 Jul 18;374(9685):260-3. doi: 10.1016/S0140-6736(09)60321-4. Epub 2009 Mar 19. Review. No abstract available. Erratum in: Lancet. 2009 Aug 22;374(9690):608.

PMID:
19303630
40.

Partnerships for blood safety in Africa: the U.S. President's Emergency Plan for AIDS Relief.

Dybul M.

Transfusion. 2008 Jun;48(6):1044-6. doi: 10.1111/j.1537-2995.2007.01752.x. No abstract available.

PMID:
18713107
41.

Virological outcome after structured interruption of antiretroviral therapy for human immunodeficiency virus infection is associated with the functional profile of virus-specific CD8+ T cells.

Daucher M, Price DA, Brenchley JM, Lamoreaux L, Metcalf JA, Rehm C, Nies-Kraske E, Urban E, Yoder C, Rock D, Gumkowski J, Betts MR, Dybul MR, Douek DC.

J Virol. 2008 Apr;82(8):4102-14. doi: 10.1128/JVI.02212-07. Epub 2008 Jan 30.

42.

Rapid expansion of the health workforce in response to the HIV epidemic.

Samb B, Celletti F, Holloway J, Van Damme W, De Cock KM, Dybul M.

N Engl J Med. 2007 Dec 13;357(24):2510-4. No abstract available.

PMID:
18077816
43.

Neglected tropical diseases and HIV/AIDS.

Dybul M.

Lancet. 2006 Nov 25;368(9550):1865. No abstract available.

PMID:
17126707
44.

Effect of long-cycle structured intermittent versus continuous HAART on quality of life in patients with chronic HIV infection.

Powers AE, Marden SF, McConnell R, Leidy NK, Campbell CM, Soeken KL, Barker C, Davey RT, Dybul MR.

AIDS. 2006 Apr 4;20(6):837-45.

PMID:
16549967
45.

Developing an evidence-based, preventive care package for persons with HIV in Africa.

Mermin J, Bunnell R, Lule J, Opio A, Gibbons A, Dybul M, Kaplan J.

Trop Med Int Health. 2005 Oct;10(10):961-70.

46.

Decreased survival of B cells of HIV-viremic patients mediated by altered expression of receptors of the TNF superfamily.

Moir S, Malaspina A, Pickeral OK, Donoghue ET, Vasquez J, Miller NJ, Krishnan SR, Planta MA, Turney JF, Justement JS, Kottilil S, Dybul M, Mican JM, Kovacs C, Chun TW, Birse CE, Fauci AS.

J Exp Med. 2004 Oct 4;200(7):587-99. Erratum in: J Exp Med. 2004 Oct 4;200(7): following 946.

PMID:
15508184
47.

Decreased survival of B cells of HIV-viremic patients mediated by altered expression of receptors of the TNF superfamily.

Moir S, Malaspina A, Pickeral OK, Donoghue ET, Vasquez J, Miller NJ, Krishnan SR, Planta MA, Turney JF, Justement JS, Kottilil S, Dybul M, Mican JM, Kovacs C, Chun TW, Birse CE, Fauci AS.

J Exp Med. 2004 Sep 6;200(5):587-99. Corrected and republished in: J Exp Med. 2004 Oct 4;200(7):587-99.

48.

A proof-of-concept study of short-cycle intermittent antiretroviral therapy with a once-daily regimen of didanosine, lamivudine, and efavirenz for the treatment of chronic HIV infection.

Dybul M, Nies-Kraske E, Dewar R, Maldarelli F, Hallahan CW, Daucher M, Piscitelli SC, Ehler L, Weigand A, Palmer S, Metcalf JA, Davey RT, Rock Kress DM, Powers A, Beck I, Frenkel L, Baseler M, Coffin J, Fauci AS.

J Infect Dis. 2004 Jun 1;189(11):1974-82. Epub 2004 May 10.

PMID:
15143462
49.

Diminished proliferation of human immunodeficiency virus-specific CD4+ T cells is associated with diminished interleukin-2 (IL-2) production and is recovered by exogenous IL-2.

Iyasere C, Tilton JC, Johnson AJ, Younes S, Yassine-Diab B, Sekaly RP, Kwok WW, Migueles SA, Laborico AC, Shupert WL, Hallahan CW, Davey RT Jr, Dybul M, Vogel S, Metcalf J, Connors M.

J Virol. 2003 Oct;77(20):10900-9.

50.

Selected topics from the 10th Conference on Retroviruses and Opportunistic Infections.

Dybul M.

HIV Clin Trials. 2003 Jul-Aug;4(4):282-6. No abstract available.

PMID:
12916014

Supplemental Content

Support Center